To determine the function of the ES open reading frame (ORF) of the human papillomaviruses (HPVs), rodent fibroblast cell lines were transfected with the E5 ORF of HPV type 6 (HPV-6) and HPV-16 expressed from an exogenous promoter. Transfected fibroblasts were transformed to colony formation in soft agar, and the transformation frequency was increased by epidermal growth factor (EGF) but not by platelet-derived growth factor. In a transitory assay, the E5 ORFs from both HPV-6 and HPV-16 were mitogenic in primary human foreskin epithelial cells (keratinocytes) and acted synergistically with EGF. Investigation of keratinocytes expressing Cervical carcinoma is among the most common cancerrelated causes of death among women worldwide (35). Infection with human papillomavirus (HPV), a small DNA tumor virus, plays a role in the malignant transformation of cervical epithelium. Of the genital HPVs, HPV type 6 (HPV-6) and HPV-11 are the most common isolates and are associated primarily with benign lesions, such as condyloma acuminata, and a portion of the premalignanant cervical intraepithelial neoplasias (19). HPV-16 and HPV-18 are associated with 60 to 90% of cervical intraepithelial neoplasias and 90% of malignant disease (19), leading to a correlation between infection with these HPV types and progression to invasive cervical cancer.
Cervical carcinoma is among the most common cancerrelated causes of death among women worldwide (35) . Infection with human papillomavirus (HPV), a small DNA tumor virus, plays a role in the malignant transformation of cervical epithelium. Of the genital HPVs, HPV type 6 (HPV-6) and HPV-11 are the most common isolates and are associated primarily with benign lesions, such as condyloma acuminata, and a portion of the premalignanant cervical intraepithelial neoplasias (19) . HPV-16 and HPV-18 are associated with 60 to 90% of cervical intraepithelial neoplasias and 90% of malignant disease (19) , leading to a correlation between infection with these HPV types and progression to invasive cervical cancer.
The papillomaviruses show a strong conservation of genetic organization (9) , and the genes of bovine papillomavirus type 1 (BPV-1) have analogous counterparts in HPV-16.
However, the activities of these analogous genes are, in some cases, different. For example, the ES open reading frame (ORF) of BPV-1 is responsible for the major transforming activity of the virus, producing foci in rodent cells, but cooperation with other viral ORFs, especially E6, is necessary for anchorage-independent growth and tumorigenesis (21) . The major immortalization and transforming activities of reside in the E6 and E7 ORFs (8, 18) , although the ES ORF may have a complementary role (14, 15, 24) . The (4) and capable of forming dimers via disulfide bonds (3) . HPV-16 E5 is structurally analogous to ES of BPV-1, but it is nearly twice the size and there is little amino acid homology between them, although there is a high degree of correlation in the hydrophobicity profiles of the two proteins (2) . The N-terminal two-thirds of each protein is hydrophobic, and the C-terminal third is hydrophilic, suggesting that ES is cell membrane associated. HPV-16 ES also has the potential for dimer formation (2) . Therefore, while there are similarities between the ES proteins of BPV-1 and HPV-16, there is no guarantee that they act via similar pathways.
Recently, BPV-1 ES was shown to alter the downregulation of the epidermal growth factor receptor (EGFR), or c-erbB, and the colony-stimulating factor receptor, or c-fins, both receptor protein-tyrosine kinases (17) . NIH 3T3 cells transfected with BPV-1 ES and the human EGFR DNAs display anchorage-independent growth and hyperphosphorylation of the receptor in the absence of the ligand epidermal growth factor (EGF). Cotransfection of ES and colonystimulating factor receptor DNA also produced transformed cells in the absence of ligand. Transfection of cells with either receptor gene alone did not result in transformation in the absence of ligand. These studies also demonstrated that the half-life of the active EGFR at the cell surface is prolonged in the presence of ligand in the ES-cotransfected cells, indicating that the downregulation of the EGFR is inhibited. However, subsequent studies by another group (31) with similarly transfected fibroblasts demonstrated that the internalization of EGFR was normal in BPV-1 ESexpressing cells, although the interaction between ligand and receptor was stabilized. In either case, the persistence of 4522 STRAIGHT ET AL. active EGFR may be responsible for the increase in proliferation of these cells, since prolonged EGFR activation has a mitogenic effect on cells (5) . This property is consistent with the hyperproliferative lesions produced in vivo by papillomaviruses. BPV-1 E5 has also been shown to interact with a complex containing the platelet-derived growth factor receptor (PDGFR) and cause hyperphosphorylation of the receptor in the absence of the ligand (23) .
Having established the ability of the ES ORF of BPV-1 to activate growth factor receptors, it is important to ask whether HPV-16 ES may induce cell proliferation via the activation of growth factor receptors. Two recent studies (14, 24) demonstrated the ability of HPV-16 ES to transform mouse fibroblasts to anchorage-independent growth but differed on the importance of growth factors in ES-mediated transformation. NIH 3T3 cells transfected with ES required EGF for efficient anchorage-independent growth (24) . 3T3-A31 cells expressing HPV-16 ES grew in soft agar independently of growth factors, although EGF but not plateletderived growth factor (PDGF) dramatically increased colony size (14) . These cells also had a variable ability to form tumors in nude mice, possibly linked to the level of ES expression (14) . Another study (15) The EGFR is present on all epithelial cells, including cervical mucosal cells (6) , and is a transmembrane receptor protein with a ligand-activated tyrosine kinase activity (5, 27) . The ligand EGF is a mitogen for keratinocytes and is essential for the growth of primary keratinocytes in vitro (25) . Ligand binding to the extracellular domain of the receptor initiates receptor dimerization and stimulates the kinase activity of the intracellular domain of the receptor (5, 27) , resulting in autophosphorylation of the receptor, which in turn initiates a cascade of events leading to the induction of cellular genes, such as c-fos, and the stimulation of DNA synthesis (7, 20) . The downregulation of the active receptor begins with the rapid endocytosis of the ligand-receptor complex in clathrin-coated vesicles (5, 27) . The endosomal compartments are acidified and subsequently fuse with lysosomes, resulting in the dissociation and degradation of the complex. Although some recycling of the EGFR to the cell surface has been observed (up to 10% in cultured epithelial cells [5] ), reconstitution of EGFR on the surface of cells following downregulation primarily involves de novo synthesis (an 8-h process) . This is in contrast, for example, to the receptors for transferrin and low-density lipoprotein, which lack an intrinsic tyrosine kinase activity and primarily recycle to the cell surface for reutilization (5, 27) .
Members of the EGFR family are frequently involved in human cancer (1, 6) , usually when there are perturbations in the control of receptor activation or down-regulation. For example, the EGFR gene is often amplified or overexpressed, or both, in squamous cell carcinomas (11, 34) , and it has been demonstrated in vitro that internalization-defective mutant receptors that retain kinase activity (32) and exogenous overexpression of the receptor (28, 29) both result in ligand-dependent transformation. In addition, constitutive activation of the kinase domain, as in the truncated receptor oncogene v-erbB, can also lead to a transformed phenotype (5 One dish of cells of each type was washed and trypsinized, and the cells were counted on a hemacytometer. The other dishes of cells were washed with Tris-buffered saline (TBS; 137 mM NaCl, 20 100-fold excess of nonradioactive hrEGF to serve as nonspecific binding controls. Nonspecific binding, typically <5%, was subtracted from the total to give specific binding. After incubation at 37°C for the times noted, dishes were rinsed three times with 2 ml of 0.15 M NaCl, cells were scraped into 1.5 ml of water with a rubber policeman, and radioactivity was counted in a Beckman gamma counter.
Internalization was monitored by an acid-salt wash procedure as previously described (12) . Following [1251I]EGF binding, the cells were washed three times with 0.15 M NaCl, and then 1 ml of ice-cold 0.2 N acetic acid-0.5 M NaCl, pH 2.5, was added for 15 s. The acid-salt wash was removed, the radioactivity in it was counted; the cells were scraped into 0.1 N NaOH, and the radioactivity in them was counted. [ 
RESULTS
Transformation of rodent fibroblasts. To examine the possibility that transforming activity is encoded by the E5 ORFs of HPV-6 and HPV-16, these genes were cloned downstream of the immediate-early gene promoter of human cytomegalovirus (hCMV; pKV6E5a and pKV16E5) and stably introduced into mouse fibroblast cell lines. Several fibroblast cell lines were used so that a more comprehensive analysis of the growth properties, focus formation, and anchorage-independent growth of E5-expressing cells was performed. Immunofluorescence with the anti-EGFR monoclonal antibody Rl allowed us to monitor the receptor from the cell surface through the endocytic pathway in cells stimulated by EGF. Figure 2 shows representative results of an immunofluorescence assay performed with normal keratinocytes aiid a keratinocyte line (pKV16E5.5) stably transfected with the pKV16E5 construct. Negative control staining with an unrelated primary antibody and appropriate secondary antibody gave no specific signal ( Fig. 2A and B) , nor did the secondary antibody alone (data not shown). Normal and E5-expressing keratinocytes exhibited abundant EGFRs at the cell surface after EGF starvation overnight (Fig. 2C and  D) . A similar surface staining pattern was observed with unpermeabilized cells (data not shown). After the addition of EGF for 1 h on ice and subsequent warming to 37°C, the normal keratinocytes followed the normal pathway of internalization and localization to perinuclear lysosomes within 60 min (Fig. 2E ) and degradation within 3 h (Fig. 2G) .
Keratinocytes expressing HPV-16 E5 appeared to display two differences in downregulation of the EGFR. First, internalization of the EGFR at the plasma membrane after ligand binding appeared to be inhibited, since EGFR could be detected at the surface of the E5-expressing cells (Fig. 2J) long after it was internalized and degraded in normal epithelial cells (Fig. 21) . However, examination of these cells 10 min after EGF addition demonstrated that the majority of the EGFRs had been internalized soon after binding EGF (immunofluorescence data not shown; see next section), but the receptors apparently returned rapidly to the cell surface.
Second, degradation of the receptor was delayed in E5-expressing cells, and receptors persisted in intracellular compartments for at least 3 h after the addition of EGF (compare Fig. 2G and H) . In several experiments, the presence of EGFR in intracellular compartments was seen up to 6 h after the addition of EGF. The addition of 10 ,uM cycloheximide to inhibit protein synthesis from the time that EGF was added had no effect on the results described here (data not shown). Table 2 shows a summary of the results from this assay with a variety of cell types. SCC-13 cells, an immortalized, EGF-dependent epithelial cell line not containing any HPV sequences, were included as a control for the effects of immortalization on this assay. Although immortal, SCC-13 cells exhibited the normal timing of EGFR downregulation seen with normal keratinocytes. Early-passage (<23rd passage) pAT16. [1251I]EGF was bound at 0°C, at which only cell surface receptors are occupied, and at 37°C, at which receptor internalization can take place, suggesting that the majority of EGFRs are on the cell surface in both normal and E5-expressing keratinocytes (Fig. 3) .
Consistent differences in the total number of receptors were observed for normal keratinocytes and cells expressing E5 ( (Fig. 4) (Fig. 5) .
Recycling of EGFR in the presence of ES. To compare the behavior of receptor-bound ligand with that of the EGFR, we followed a protocol similar to the one used in the viously incubated with nonradioactive EGF, as expected, because the receptors were already occupied. After 2 to 6 h, there was a marked increase in the number of receptors available to bind [125I]EGF on the pKV16E5 cells (40% recycled) but little increase in the normal keratinocytes (7% recycled). The EGFR was therefore more resistant to degradation in cells expressing E5, even though receptor-bound EGF seemed to be degraded at the same rate in normal keratinocytes and pKV16E5 cells (Fig. 5) .
The use of radiolabeled EGF demonstrated the similarities and differences in EGFR kinetics between normal keratinocytes and E5-expressing cells. Both cell types displayed the same rate of receptor internalization, ligand affinity, and ligand degradation to TCA-soluble fragments. However, the E5-expressing cells possess a greater number of EGFRs than do normal keratinocytes, and after ligand stimulation, the receptors appear to be recycled to a greater degree in the E5-expressing cells than in controls.
Double-labeling experiments with cells stimulated with FITC-labeled EGF, fixed, and then stained for EGFRs with monoclonal antibody Rl and a rhodamine-labeled secondary antibody also demonstrated recycling of the EGFR in E5-expressing cells (Fig. 8) . The EGFRs on the surface of the cells (Fig. 8A and B) internalized rapidly in both normal and E5-expressing keratinocytes (Fig. 8C and D) , but then reappeared on the surface of the E5-expressing cells but not normal keratinocytes (Fig. 8E and F) . Furthermore, EGF and the EGFR had different destinations after internalization in E5-expressing keratinocytes, since EGF-FITC was degraded in the perinuclear lysosomes (arrows, Fig. 8F ), while a portion of the EGFRs reappeared at the cell surface (Fig.  8F) . Permeabilized preparations allowed the observation of internalized EGFRs, and a portion were observed to be localized to the perinuclear compartments after stimulation (data not shown, but see Fig. 2E and F). In the normal keratinocyte, both EGF and the EGFR are degraded in lysosomes (Fig. 8E) . Competition with unlabeled human EGF abolished the signal from EGF-FITC. It should be noted that EGF-FITC was soluble in the Triton X-100 solution, so the localization of EGF-FITC is solely from fixed, unpermeabilized cells. Finally, the addition of 10 ,uM cyclohexamide to inhibit protein synthesis during this experiment had no effect on the results described here.
Phosphorylation of the EGFR. To determine the biological activity of the EGFR in cells expressing HPV-16 E5, we examined the phosphorylation state of the EGFR as a measure of the tyrosine kinase activity of the receptor. Phosphorylated proteins were immunoprecipitated with an anti-phosphotyrosine monoclonal antibody from lysates of 32Pi-labeled cells starved of EGF or stimulated with a saturating concentration of ligand for various times. The immunoprecipitate from 106 cells was separated by SDSpolyacrylamide gel electrophoresis (PAGE) and autoradiographed (Fig. 9) . The tyrosine kinase activity and the phos- (Fig. 10) to confirm that the observed increase in phosphorylation occurred on tyrosine residues in response to ligand-stimulated kinase activity. Keratinocytes with and without E5 were stimulated with EGF, and whole-cell lysates were prepared. Aliquots of the same lysates were electrophoresed, transferred to nitrocellulose, and stained with monoclonal antibodies to either the EGFR or phosphotyrosine. EGFR-specific staining was evident for all the time points examined for all the cell types tested (Fig. 10A) . Staining for phosphotyrosine (Fig. 10B) indication that there was an increase in tyrosine phosphorylation (13) .
DISCUSSION
In our studies, HPV-6 E5 and HPV-16 E5 were able to transform a number of rodent fibroblast cell lines, and the transformation rate of fibroblasts by E5 was greater in the presence of EGF but not of PDGF. These results support the results of the previous studies on the ability of HPV-16 E5 alone to transform fibroblasts (14) and reinforce the fact that EGF (14, 24) but not PDGF (14) can increase transformation efficiency.
The mitogenic response of DNA synthesis occurs subsequent to the induction of early genes, such as c-fos (7). Fibroblasts transfected with HPV-16 E5 expressed increased amounts of c-fos mRNA after EGF stimulation compared with untransfected fibroblasts (14) . In our work, we found that the E5 ORFs of cells. Third, the immunofluorescence studies indicated that there is a significant amount of receptor on the surface of E5-expressing cells after the initial internalization, while the kinetic studies with ['"IJEGF showed that the internalization and degradation of the ligand were normal. One explanation for the separation of the receptor and ligand pathways after internalization would be that in the event of inhibition of degradation of the receptor, the receptors recycle back to the cell surface. Support for this explanation came from the results shown in Fig. 7 . This experiment showed that 40% of the receptors in E5-expressing cells recycled, as opposed to 7% in the control cells. As these recycled receptors bind ligand, they are assumed to be restimulated for signal transduction. Further support for this explanation comes from the double-labeling experiments with EGF-FITC. In this experiment, EGF and the EGFR were observed to follow different routes after internalization in E5-expressing cells: EGF proceeded to the perinuclear lysosomes for eventual degradation, while a significant proportion of the EGFRs reappeared at the cell surface. The use of cycloheximide to inhibit translation of the EGFR had no effect on the immunofluorescence study results, indicating that the de novo synthesis of EGFR could not account for the reappearance of receptor at the cell surface.
The separation of the ligand and receptor indicates an alteration in the compartmentalization process in the E5-expressing cell following endocytosis of the ligand-receptor complex. This may occur if there is a delay in the acidification of the endosomal compartments of E5-expressing cells, since acidification is responsible for dissociation of the ligand-receptor complex in the endosome and is necessary for subsequent proteolysis. This delay in acidification may allow the partitioning of the receptor to a recycling pathway and may be due to the action of E5, since it has been shown that the BPV-1 E5 can bind to a subunit of the vacuolar proton-ATPase associated with ion transport pumps (10), including the pump responsible for endosome acidification. Recent work on BPV-1 E5 shows that the protein appears to decrease the rate of degradation of the EGFR by stabilizing intact EGF-EGFR complexes in fibroblasts transfected with human EGFR (31), perhaps also because of the effect of E5 on endosome acidification.
The activity of the EGFR can be assessed by its level of tyrosine phosphorylation after stimulation with ligand. Our data suggested that there was no difference in the constitutive level of phosphorylation between E5-expressing and control cells. This is a different situation than with BPV-1 E5, which causes phosphorylation of the EGFR (17) and PDGFR (23) on rodent fibroblasts in the absence of ligand. BPV-1 E5 interacts with a complex which contains the PDGFR (22) , and, since BPV-1 E5 can dimerize, perhaps causes dimerization and autophosphorylation of the PDGFR. While HPV-16 E5 has the potential to dimerize (2), it is currently unknown whether it binds to the EGFR. Regardless, our data indicate that HPV-16 E5 does not cause autophosphorylation of the EGFR in the absence of ligand. Upon ligand stimulation, however, there was an increase in the level of phosphorylation of the receptor in E5-expressing cells that appeared greater than that predicted by the increased receptor number on these cells. This was true for cells containing the whole genome or E5 alone. Furthermore, this hyperphosphorylation persisted for at least an hour in the E5-expressing cells, while the control cells returned to their basal state. Finally, the immunoblots in Fig.  10 demonstrated that the hyperphosphorylation of EGFR in E5-expressing cells included tyrosine residues.
In our receptor phosphorylation studies, HPV-16 E5 did not constitutively activate the EGFR of keratinocytes. This is unlike BPV-1 E5, which activates growth factor receptors in the absence of exogenous ligand (17, 23) . Additionally, HPV-6 E5 and HPV-16 E5 transformed fibroblasts to anchorage-independent growth in the absence of exogenous ligand. Both E5 ORFs were also mitogenic stimuli for keratinocytes in our transient-transfection assay. These facts demonstrate that HPV-16 E5 may act through several pathways, one involving the EGFR and another independent of it, possibly in a cell type-specific manner, or that E5 affects some point downstream of the EGFR in the receptormediated endocytosis/signal transduction pathway, such as the proton-ATPase pump. This second possibility would appear to conflict with the inability of PDGF to enhance transformation of rodent fibroblasts, since the EGFR and the PDGFR share a similar receptor-mediated endocytosis pathway. However, this could be explained by the fact that the PDGFR is not a major growth factor receptor on keratinocytes, and HPV-16 E5 may have some specificity for the primary growth factor receptors of the normal host cell type for HPVs. Clearly, there are several questions about the role of the HPV-16 E5 ORF in HPV infection and its interaction with cellular signal transduction pathways that warrant further study.
